Details of the Drug

General Information of Drug (ID: DMHHXC9)

• Drug Name: NSI-566
• Synonyms: Neural stem cell therapy (ALS, spinal cord injury, paraplegia), Neuralstem; Spinal cord stem cell therapy (ALS, spinal cord injury, paraplegia), Neuralstem; Neural stem cell therapy (ALS, spinal cord injury, paraplegia, stroke), Neuralstem

Indication

Disease Entry	ICD 11	Status	REF
Amyotrophic lateral sclerosis	8B60.0	Phase 2	[1]
Cerebrovascular ischaemia	8B1Z	Phase 2	[2]
Lateral sclerosis	8B61	Phase 2	[2]
Spinal cord injury	ND51.2	Phase 1	[1]

• Cross-matching ID:
  DrugBank ID: DB17954
  TTD ID: D0J9VG
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025566)